Yale SPORE in Lung Cancer Career Development Program

项目摘要 在肺癌领域工作的医生科学家和翻译研究人员的数量没有跟上时代的步伐。 医学研究界的整体增长或我们基础知识的增长， 越来越多的未实现的基础和转化研究机会。耶鲁是唯一适合 帮助重建这个基地，我们坚定地致力于基础和转化研究。职业 耶鲁大学肺癌研究生院（YSILC）的发展计划（CDP）旨在为肺癌的研究做出贡献。 这对正在进行的努力和试图解决这一问题的新举措具有实质性意义。我们的翻译 耶鲁大学的研究办公室（由Herbst博士领导）一直致力于提供早期种子资金， 翻译支持年轻的研究人员在他们的研究生涯的早期。CDP的目标是教育 致力于肺癌转化研究的新一代研究人员。CDP有很大的 在资金和基础设施方面的体制承诺。潜在的CDP候选人包括 有前途的初级教师谁有兴趣建立自己的职业生涯在转化肺癌研究或 建立了以前研究过其他领域的研究人员。初级教员获奖者将 与肺癌研究中更成熟的研究人员配对， 指导。通过这种方式，YSILC将刺激下一代医生科学家的发展 和翻译研究人员，解决肺癌研究中最具挑战性的问题。

PROJECT SUMMARY The number of physician-scientists and translational researchers working in lung cancer has not kept pace with the overall growth of the medical research community or with the growth in our basic knowledge base, resulting in an increasing number of unrealized basic and translational research opportunities. Yale is uniquely suited to helping rebuild this base with our strong commitment to basic and translational research. The Career Development Program (CDP) in the Yale SPORE in Lung Cancer (YSILC) has been designed to contribute substantively to ongoing efforts and new initiatives attempting to address this problem. Our translational research office at Yale (led by Dr. Herbst) has been committed to providing early seed funding and translational support to young investigators early in their research careers. The goal of the CDP is to educate a new generation of investigators committed to translational research in lung cancer. The CDP has substantial institutional commitment, both in terms of funding and infrastructure. Potential CDP candidates include promising junior faculty who are interested in establishing their career in translational lung cancer research or established investigators whose previous research has been in other areas. Junior faculty awardees will be paired with more established investigators in lung cancer research with a documented record of successful mentoring. In this way, the YSILC will stimulate the development of the next generation of physician scientists and translational researchers, addressing the most challenging issues in lung cancer research.